Remedium Lifecare Ltd — Board Meeting, 17-04-2025: Board Meeting

Remedium Lifecare Ltd. has announced a board meeting on April 24, 2025, to approve a Rights Issue of 49,19,04,000 equity shares at Re. 1 each, totalling ₹491.90 cr for existing shareholders. This move aims to strengthen the company's financial position and facilitate future growth. The trading window has been closed since April 1, 2025, and will remain so until 48 hours after the release of the audited financial results for the year ending March 31, 2025. Investors may view this Rights Issue as a strategic opportunity for capital raising, potentially enhancing shareholder value in the long run.